Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
Go back to Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.83 -0.27 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.10 | 52 Week High | $45.34 | |||
| Open | $6.12 | 52 Week Low | $15.92 | |||
| Day High | $6.12 | P/E | 2.50 | |||
| Day Low | $5.73 | EPS | $2.33 | |||
| Volume | 856,980 | |||||
